Working… Menu

Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02739217
Recruitment Status : Completed
First Posted : April 15, 2016
Last Update Posted : August 29, 2018
Information provided by (Responsible Party):
ProMetic BioSciences Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 26, 2017
Actual Study Completion Date : June 4, 2018